Soligenix
SNGX
#10202
Rank
โ‚ฌ10.83 M
Marketcap
1,07ย โ‚ฌ
Share price
0.82%
Change (1 day)
-50.47%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -โ‚ฌ11.18 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ8.17 Million a decrease over its 2023 earnings that were of -โ‚ฌ6.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ11.18 Million36.84%
2024 -โ‚ฌ8.17 Million22.96%
2023 -โ‚ฌ6.64 Million-45.74%
2022 -โ‚ฌ12.24 Million11.88%
2021 -โ‚ฌ10.94 Million-32.37%
2020 -โ‚ฌ16.18 Million83.18%
2019 -โ‚ฌ8.83 Million11.57%
2018 -โ‚ฌ7.92 Million19.29%
2017 -โ‚ฌ6.64 Million33%
2016 -โ‚ฌ4.99 Million-19.7%
2015 -โ‚ฌ6.22 Million5.16%
2014 -โ‚ฌ5.91 Million
2010 -โ‚ฌ6.67 Million26.12%
2009 -โ‚ฌ5.29 Million75.1%
2008 -โ‚ฌ3.02 Million-45.38%
2007 -โ‚ฌ5.53 Million-22.84%
2006 -โ‚ฌ7.17 Million66.15%
2005 -โ‚ฌ4.32 Million-16.65%
2004 -โ‚ฌ5.18 Million13.28%
2003 -โ‚ฌ4.57 Million-11.88%
2002 -โ‚ฌ5.19 Million-59.44%
2001 -โ‚ฌ12.78 Million378.18%
2000 -โ‚ฌ2.68 Million-38.53%
1999 -โ‚ฌ4.35 Million-18.43%
1998 -โ‚ฌ5.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.29 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.35 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.94 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-โ‚ฌ15.86 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ36.48 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.87 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-โ‚ฌ2.41 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA